J0601 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
J0601 is a HCPCS Level II code for sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis). It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J0601
- Long descriptor
- Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- Short descriptor
- Sevelamer carbonate 20 mg
- Added
- January 1, 2025
- BETOS
- O1E
- Pricing indicator
- 57 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Other carrier priced.
Codes adjacent to J0601
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0601 is not quite right, the correct code is very often within a few positions of it.
- J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
- J0594injection, busulfan, 1 mg
- J0595Injection, butorphanol tartrate, 1 mg
- J0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
- J0597Injection, c-1 esterase inhibitor (human), berinert, 10 units
- J0598Injection, c-1 esterase inhibitor (human), cinryze, 10 units
- J0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
- J0600Injection, edetate calcium disodium, up to 1000 mg
- J0602Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606Injection, etelcalcetide, 0.1 mg
- J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
Questions about J0601
What is HCPCS code J0601?
J0601 is a HCPCS Level II code for sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis). It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0601?
The CMS HCPCS file marks J0601 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J0601 paid under the physician fee schedule?
J0601 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).